Metagenomi Therapeutics, Inc. (MGX) 8-K filings
- Ticker
- MGX (Nasdaq)
- SEC CIK
- 1785279
- Industry (SIC)
- 2836 Biological Products, (No Diagnostic Substances)
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-10 16:07 | 8-K | 2.02 Earnings release | Details |